Ignite Creation Date:
2024-05-06 @ 6:30 PM
Last Modification Date:
2025-12-16 @ 2:22 PM
Study NCT ID:
NCT05689203
Status:
None
Last Update Posted:
2023-01-19 00:00:00
First Post:
2023-01-15 00:00:00
Brief Title:
A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19
Sponsor:
Qilu Pharmaceutical Co Ltd
Organization:
Qilu Pharmaceutical Co., Ltd.
Organization Data
Organization:
Qilu Pharmaceutical Co., Ltd.
Class:
INDUSTRY
Study ID:
QLS1128-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Qilu Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None